Variation in genes implicated in serotonin neurotransmission may interact with environmental factors to influence antidepressant response. We aimed to determine how a range of polymorphisms in serotonergic genes determine this response to treatment and how they interact with childhood trauma and recent life stress in a Chinese sample. In total, 14 single nucleotide polymorphisms (SNPs) in coding regions of 10 serotonergic genes (HTR1A, HTR1B, HTR1D, HTR2A, HTR3A, HTR3C, HTR3D, HTR3E, HTR5A and TPH2) were genotyped in 308 Chinese Han patients with major depressive disorder. Response to 6 weeks’ antidepressant treatment was determined by change in the 17-item Hamilton Depression Rating Scale (HDRS-17) score, and previous stressful events were evaluated by the Life Events Scale (LES) and Childhood Trauma Questionnaire-Short Form (CTQ-SF). Two 5-HT1B receptor SNPs (rs6296 and rs6298) and one tryptophan hydroxylase2 (rs7305115) SNP were significantly associated with antidepressant response in this Chinese sample, as was a haplotype in TPH2 (rs7305115 and rs4290270). A gene–gene interaction on antidepressant response was found between SNPs in HTR1B, HTR3A and HTR5A in female subjects. The HTR1B SNPs demonstrated interaction with recent stress, while that for TPH2 interacted with childhood trauma to influence antidepressant response.
American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington: American Psychiatric Press.
2.
BauerMBschorTPfennigAWhybrowPCAngstJVersianiM. (2007) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry8: 67–104.
3.
BauerMWhybrowPCAngstJVersianiMMollerHJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry3: 5–43.
4.
BelmakerRHAgamG (2008) Mechanisms of Disease Major Depressive Disorder. N Engl J Med358: 55–68.
5.
BenjaminiYHochbergY (1995) Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical SocietyB(57): 289–300.
6.
BemsteinD PFinkL (1998)Childhood Trauma Questionnaire A retrospective self-report Manual. The Psychological Corporation, Harcourt Brace & Company, San Antonio.
7.
BirkettJTArranzMJMunroJOsbournSKerwinRWCollierDA (2000) Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport11: 2017–2020.
8.
BrownKMBujacSRMannETCampbellDAStubbinsMJBlundellJE (2007) Further evidence of association of OPRD1 & HTR1D polymorphisms with susceptibility to anorexia nervosa. Biol Psychiatry61: 367–373.
9.
BukhJDBockCVinbergMWergeTGetherUKessingLV (2010) No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment. Eur Neuropsychopharmacol20: 327–335.
10.
CartegniLChewSLKrainerAR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet3: 285–298.
11.
CaspiASugdenKMoffittTETaylorACraigIWHarringtonH. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science301: 386–389.
12.
ClarkMSNeumaierJF (2001) The 5-HT1B receptor: behavioral implications. Psychopharmacol Bull35: 170–185.
13.
DavidgeKMAtkinsonLDouglasLLeeVShapiroSKennedyJL. (2004) Association of the serotonin transporter and 5-HT1D receptor genes with extreme, persistent and pervasive aggressive behaviour in children. Psychiatr Genet14: 143–146.
14.
DuanJSandersARMolenJEMartinolichLMowryBJLevinsonDF. (2003) Polymorphisms in the 5’-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression. Mol Psychiatry8: 901–910.
15.
DubovskySLThomasM (1995) Beyond specificity: effects of serotonin and serotonergic treatments on psychobiological dysfunction. J Psychosom Res39: 429–444.
EI HageWPowellJFSurguladzeSA (2009) Vulnerability to depression: what is the role of stress genes in gene × environment interaction?Psychol Med39: 1407–1411.
18.
EnochMAHodgkinsonCAYuanQShenPHGoldmanDRoyA (2010) The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. Biol Psychiatry67: 20–27.
19.
FuWYaoS (2005) Initial reliability and validity of Childhood Trauma Questionnaire (CTQ-SF) applied in Chinese college students. Chin J Clin Psychol13: 40–42.
20.
GardnerKLHaleMWOldfieldSLightmanSLPlotskyPMLowryCA (2009) Adverse experience during early life and adulthood interact to elevate TPH2 mRNA expression in serotonergic neurons within the dorsal raphe nucleus. Neuroscience163: 991–1001.
21.
GuyW (1976) ECDEU Assessment Manual for Psychopharmacology Revised. USA Rockville DEW.
22.
HamiltonM (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry23: 56–62.
23.
HartigPRBranchekTAWeinshankRL (1992) A subfamily of 5-HT1D receptor genes. Trends Pharmacol Sci13: 152–159.
24.
HolenzJPauwelsPJDíazJLMercèRCodonyXBuschmannH (2006) Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents. Drug Discov Today11: 283–299.
25.
HongCJChenTJYuYWTsaiSJ (2006) Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J6: 27–33.
26.
HorstmannSBinderEB (2009) Pharmacogenomics of antidepressant drugs. Pharmacol Ther124: 57–73.
27.
HuangYYOquendoMAFriedmanJMGreenhillLLBrodskyBMaloneKM. (2003) Substance misuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology28: 163–169.
28.
InvernizziRW (2007) Role of TPH-2 in brain function: news from behavioral and pharmacologic studies. J Neurosci Res85: 3030–3035.
29.
JonesMDLuckiI (2005) Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology30: 1039–1047.
30.
KatoMFukudaTWakenoMOkugawaGTakekitaYWatanabeS. (2009) Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet150B: 115–123.
31.
KeersRUherRGuptaBRietschelMSchulzeTHauserJ. (2010) Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. J Affective Dis127: 337–342.
32.
KeersRUherRHuezo-DiazPSmithRJaffeeSRietschelM. (2011) Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Pharmacogenomics J11: 138–145.
33.
LeeSHLeeKJLeeHJHamBJRyuSHLeeMS (2005) Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatry Clin Neurosci59: 140–145.
34.
LemondeSTureckiGBakishDDuLHrdinaPDBownCD. (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci23: 8788–8799.
35.
LimJEPinsonneaultJSadeeWSaffenD (2007) Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol Psychiatry12: 491–501.
36.
LohoffFWFerraroTN (2010) Pharmacogenetic considerations in the treatment of psychiatric disorders. Expert Opin Pharmacother11: 423–439.
37.
LouXYChenGBYanLMaJZZhuJElstonRC. (2007) Ageneralized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet80: 1125–1137.
38.
LotrichFEPollockBG (2005) Candidate genes for antidepressant response to selective serotonin reuptake inhibitors. Neuropsychiatr Dis Treat1: 17–35.
39.
McMahonFJBuervenichSCharneyDLipskyRRushAJWilsonAF. (2006) Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet78: 804–814.
40.
MandelliLMarinoEPirovanoACalatiRZanardiRColomboC. (2009) Interaction between 5-HTTLPR and stressful life events on response to antidepressant treatment. Eur Neuropsychopharmacol19: 64–67.
41.
MiniatiMRucciPBenvenutiAFrankEButtenfieldJGiorgiG. (2009) Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse. J Psychiatr Res44: 302–309.
42.
MusazziLMalleiATarditoDGruberSHEl KhouryARacagniG. (2009) Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene–environment model of depression. J Psychiatr Res44: 511–520.
43.
NemeroffCBValeWW (2005) The neurobiology of depression: inroads to treatment and new drug discovery. J Clin Psychiatry7: 5–13.
44.
Newton-ChehCHirschhornJN (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res573: 54–69.
45.
OhtsukiTIshiguroHDetera-WadleighSDToyotaTShimizuHYamadaK. (2002) Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees. Mol Psychiatry7: 954–961.
46.
ParseyRVOlvetDMOquendoMAHuangYYOgdenRTMannJJ (2006) Higher 5-HT(1A) receptor binding potential during a major depressive episode predicts poor treatment response: Preliminary data from a naturalistic study. Neuropsychopharmacology31: 1745–1749.
47.
PerroudNAitchisonKJUherRSmithRHuezo-DiazPMarusicA. (2009) Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology34: 2517–2528.
48.
PetersEJSlagerSLJenkinsGDReinaldaMSGarriockHAShynSI. (2009) Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics19: 1–10.
49.
PetersEJSlagerSLMcGrathPJKnowlesJAHamiltonSP (2004) Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry9: 879–889.
50.
PickarDRubinowK (2001) Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci22: 75–83.
51.
RauschJLJohnsonMEFeiYJLiJQShendarkarNHobbyHM. (2002) Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry51: 723–732.
52.
SchosserAKasperS (2009) The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol24: 277–288.
53.
SerrettiAArtioliPDe RonchiD (2004) The 5-HT2C receptor as a target for mood disorders. Expert Opin Ther Targets8: 15–23.
54.
SerrettiABenedettiFZanardiRSmeraldiE (2005) The influence of Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry29: 1074–1084.
55.
ShishkinaGTKalininaTSDygaloNN (2007) Up-regulation of tryptophan hydroxylase-2 RNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect. Neuroscience150: 404–412.
56.
SmollerJWBiedermanJArbeitmanLDoyleAEFagernessJPerlisRH. (2006) Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry59: 460–467.
57.
SunNXuYWangYDuanHWangSRenY. (2008) The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population. J Neural Transm115: 1681–1686.
58.
TanakaMKobayashiDMurakamiYOzakiNSuzukiTIwataN. (2008) Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea. Int J Neuropsychopharmacol11: 261–267.
59.
ThomasDR (2006) 5-ht5A receptors as a therapeutic target. Pharmacol Ther111: 707–714.
60.
ThombsBDBernsteinDPLobbestaelJArntzA (2009) A validation study of the Dutch Childhood Trauma Questionnaire-Short Form: Factor structure, reliability, and known-groups validity. Child Abuse Negl33: 518–523.
61.
TsaiSJHongCJLiouYJYuYWChenTJHouSJ. (2009) Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response. Prog Neuropsychopharmacol Biol Psychiatry33: 637–641.
62.
TzvetkovMVBrockmöllerJRootsIKirchheinerJ (2008) Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment. Pharmacogenet Genomics18: 495–506.
63.
UherRPerroudNNgMYHauserJHenigsbergNMaierW. (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry167: 555–564.
64.
VázquezDMEskandariRZimmerCALevineSLópezJF (2002) Brain 5-HT receptor system in the stressed infant rat:implications for vulnerability to substance abuse. Psychoneuroendocrinology27: 245–272.
65.
VillafuerteSMVallabhaneniKSliwerskaEMcMahonFJYoungEABurmeisterM (2009) SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. Psychiatr Genet19: 281–291.
66.
WetzelCHHermannBBehlCPestelERammesGZieglgänsbergerW. (1998) Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol12: 1441–1451.
67.
YamadaKHattoriEIwayamaYOhnishiTOhbaHToyotaT. (2006) Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry60: 192–201.
68.
YangDSZhangYL (1999) Life Event Scales (LES) In: WangXDWangXLMaH (eds) Rating Scales for Mental Health. Chinese Mental Health Journal101–106.
69.
ZoharJKennedyJLHollanderEKoranLM (2004) Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. J Clin Psychiatry14: 18–21.
